Skip to content

EV / sales at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
6.5×+1.8×
Bausch Health Companies logo
Bausch Health CompaniesBHC
-0.3×
IAR
Integra LifeSciencesIART
1.5×-0.6×
ITG
Integer HoldingsITGR
2.4×-0.8×
Glaukos logo
GlaukosGKOS
11.3×-2.4×
HRO
HarrowHROW
5.7×-0.6×

Other financials

Income statement

See full
Revenue$93.5M+120%
Gross profit$68.9M+146%
Operating income$8.0M+114%
Net income$5.2M+110%
EPS (diluted)$0.10+109%

Balance sheet

See full
Cash & equivalents$131.9M-23.8%
Total debt$37.3M+1.7%
Total equity$352.4M+0.7%
Total assets$451.1M-1.4%

Cash flow

See full
Operating cash flow-$21.7M-278%
CapEx$443.0K-69.8%
Free cash flow-$22.1M-207%

Valuation

See full
Market cap$1.44B+77.9%
Enterprise value$1.35B+100.0%
P/S+2.1×

Profitability

See full
Gross margin76.9%+2.9pp
Operating margin-9.1%-3.5pp
Net margin-7.2%-3.0pp
FCF margin-19.6%+55.9pp

Returns & leverage

See full
Return on equity-6%-2.4pp
Debt / equity0.1×0.0×
Current ratio5.1×+0.3×

Where this comes from

Calculated from Staar Surgical’s reported figures.

Based on the most recent quarter.

The official record: Staar Surgical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Staar Surgical's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Staar Surgical's EV / sales?
Staar Surgical (STAA) reported EV / sales of 4.2× in Q1 2026.
How has Staar Surgical's EV / sales changed year-over-year?
Staar Surgical's EV / sales increased by 55.4% year-over-year, from 2.7× to 4.2×.
What is the long-term trend for Staar Surgical's EV / sales?
Over 5 years (2020 to 2025), Staar Surgical's EV / sales has grown at a -34.8% compound annual growth rate (CAGR), from 29× to 3.4×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.